{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T14:15:46Z","timestamp":1791209746982,"version":"4.1.0"},"reference-count":78,"publisher":"American Society for Microbiology","issue":"11","license":[{"start":{"date-parts":[[2002,11,1]],"date-time":"2002-11-01T00:00:00Z","timestamp":1036108800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.asm.org\/non-commercial-tdm-license"}],"content-domain":{"domain":["journals.asm.org"],"crossmark-restriction":true},"short-container-title":["Antimicrob Agents Chemother"],"published-print":{"date-parts":[[2002,11]]},"abstract":"<jats:title>ABSTRACT<\/jats:title><jats:p>The immunosuppressive macrolide rapamycin is used in humans to prevent graft rejection. This drug acts by selectively repressing the translation of proteins that are encoded by an mRNA bearing a 5\u2032-polypyrimidine tract (e.g., ribosomal proteins, elongation factors). The human immunodeficiency virus type 1 (HIV-1) carries a polypyrimidine motif that is located within the<jats:italic>tat<\/jats:italic>exon 2. Treatment of human T lymphoid cells with rapamycin resulted in a marked diminution of HIV-1 transcription when infection was performed with luciferase reporter T-tropic and macrophage-tropic viruses. Replication of fully infectious HIV-1 particles was abolished by rapamycin treatment. The rapamycin-mediated inhibitory effect on HIV-1 production was reversed by FK506. The anti-HIV-1 effect of rapamycin was also seen in primary human cells (i.e., peripheral blood lymphocytes) from different healthy donors. Rapamycin was shown to diminish basal HIV-1 long terminal repeat gene expression, and the observed effect of rapamycin on HIV-1 replication seems to be independent of the virus-specific transactivating Tat protein. A constitutive \u03b2-actin promoter-based reporter gene vector was unaffected by rapamycin treatment. Kinetic virus infection studies and exposure to reporter viruses pseudotyped with heterologous envelope proteins (i.e., amphotropic murine leukemia virus and vesicular stomatitis virus G) suggested that rapamycin is primarily affecting the life cycle of HIV-1 at a transcriptional level. Northern blot analysis confirmed that this compound is selectively targeting HIV-1 mRNA synthesis.<\/jats:p>","DOI":"10.1128\/aac.46.11.3447-3455.2002","type":"journal-article","created":{"date-parts":[[2002,10,16]],"date-time":"2002-10-16T23:01:16Z","timestamp":1034809276000},"page":"3447-3455","update-policy":"https:\/\/doi.org\/10.1128\/asmj-crossmark-policy-page","source":"Crossref","is-referenced-by-count":68,"title":["The Immunosuppressant Rapamycin Represses Human Immunodeficiency Virus Type 1 Replication"],"prefix":"10.1128","volume":"46","author":[{"given":"Jocelyn","family":"Roy","sequence":"first","affiliation":[{"name":"Centre de Recherche en Infectiologie, Ho\u0302pital CHUL, Centre Hospitalier Universitaire de Que\u0301bec, and De\u0301partement de Biologie Me\u0301dicale, Faculte\u0301 de Me\u0301decine, Universite\u0301 Laval, Ste-Foy, Que\u0301bec, Canada G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Se\u0301bastien","family":"Paquette","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Infectiologie, Ho\u0302pital CHUL, Centre Hospitalier Universitaire de Que\u0301bec, and De\u0301partement de Biologie Me\u0301dicale, Faculte\u0301 de Me\u0301decine, Universite\u0301 Laval, Ste-Foy, Que\u0301bec, Canada G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Franc\u0327ois","family":"Fortin","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Infectiologie, Ho\u0302pital CHUL, Centre Hospitalier Universitaire de Que\u0301bec, and De\u0301partement de Biologie Me\u0301dicale, Faculte\u0301 de Me\u0301decine, Universite\u0301 Laval, Ste-Foy, Que\u0301bec, Canada G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel J.","family":"Tremblay","sequence":"additional","affiliation":[{"name":"Centre de Recherche en Infectiologie, Ho\u0302pital CHUL, Centre Hospitalier Universitaire de Que\u0301bec, and De\u0301partement de Biologie Me\u0301dicale, Faculte\u0301 de Me\u0301decine, Universite\u0301 Laval, Ste-Foy, Que\u0301bec, Canada G1V 4G2"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"235","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.14.1.483"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.59.2.284-291.1986"},{"key":"e_1_3_2_4_2","doi-asserted-by":"crossref","first-page":"22825","DOI":"10.1016\/S0021-9258(18)41602-X","volume":"268","year":"1993","unstructured":"Albers, M. W., R. T. Williams, E. J. Brown, A. Tanaka, F. L. Hall, and S. L. Schreiber. 1993. FK506-binding proteins-rapamycin inhibits a cyclin-dependent kinase activity and a cyclin D1-Cdk association in early G1 of an osteosarcoma cell line. J. Biol. Chem.268:22825-22829.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_5_2","first-page":"1163","volume":"337","year":"1991","unstructured":"Bardini, G., M. C. Re, G. Rosti, and A. R. Belardinelli. 1991. HIV infection and bone-marrow transplantation. Lancet337:1163-1164.","journal-title":"Lancet"},{"key":"e_1_3_2_6_2","first-page":"S3","volume":"11","year":"1997","unstructured":"Berger, E. A. 1997. HIV entry and tropism: the chemokine receptor connection. AIDS11:S3-S16.","journal-title":"AIDS"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.4.2451-2461.1995"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1038\/382829a0"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.76.3.1004-1014.2002"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.70.8.5170-5176.1996"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.277.5322.99"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.69.7.4267-4273.1995"},{"key":"e_1_3_2_13_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(93)90092-L"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.3.1922-1930.1997"},{"key":"e_1_3_2_15_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.gt.3300895"},{"key":"e_1_3_2_16_2","first-page":"654","volume":"62","year":"1994","unstructured":"Chen, B., K. Saksela, R. Andino, and D. Baltimore. 1994. Distinct modes of human immunodeficiency virus type 1 proviral latency revealed by superinfection of nonproductively infected cell lines with recombinant luciferase-encoding viruses. J. Virol.62:654-660.","journal-title":"J. Virol."},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.26.12574"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0092-8674(00)81313-6"},{"key":"e_1_3_2_19_2","first-page":"532","volume":"15","year":"1993","unstructured":"Chomczynski, P. 1993. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. BioTechniques15:532-536.","journal-title":"BioTechniques"},{"key":"e_1_3_2_20_2","first-page":"156","volume":"162","year":"1987","unstructured":"Chomczynski, P., and N. Sacchi. 1987. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem.162:156-159.","journal-title":"Anal. Biochem."},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.1038\/357695a0"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1126\/science.270.5243.1811"},{"key":"e_1_3_2_23_2","first-page":"423","volume":"26","year":"2001","unstructured":"Coull, J. J., D. Turner, T. Melby, M. R. Betts, R. Lanier, and D. M. Margolis. 2001. A pilot study of the use of mycophenolate mofetil as a component of therapy for multidrug-resistant HIV-1 infection. J. Acquired Immune Defic. Syndr.26:423-434.","journal-title":"Syndr."},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029901000101"},{"key":"e_1_3_2_25_2","doi-asserted-by":"publisher","DOI":"10.1038\/381661a0"},{"key":"e_1_3_2_26_2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4049\/jimmunol.144.1.251","volume":"144","year":"1990","unstructured":"Dumont, F. J., M. J. Staruch, S. L. Koprak, M. R. Melino, and N. H. Sigal. 1990. Distinct mechanisms of suppression of murine T-cell activation by the related macrolides FK-506 and rapamycin. J. Immunol.144:251-258.","journal-title":"J. Immunol."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.5.3588-3596.1997"},{"key":"e_1_3_2_28_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1996.0421"},{"key":"e_1_3_2_29_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.biochem.67.1.1"},{"key":"e_1_3_2_30_2","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M202014200"},{"key":"e_1_3_2_31_2","first-page":"221","volume":"11","year":"1992","unstructured":"Hanke, J. H., L. N. Nichols, and M. E. Coon. 1992. FK506 and rapamycin selectively enhance degradation of IL-2 and GM-CSF mRNA. Lymphokine Cytokine Res.11:221-231.","journal-title":"Lymphokine Cytokine Res."},{"key":"e_1_3_2_32_2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0166-3542(02)00006-2","volume":"55","year":"2002","unstructured":"Hossain, M. M., J. J. Coull, G. L. Drusano, and D. M. Margolis. 2002. Dose proportional inhibition of HIV-1 replication by mycophenolic acid and synergistic inhibition in combination with abacavir, didanosine, and tenofovir. Antiviral Res.55:41-52.","journal-title":"Antiviral Res."},{"key":"e_1_3_2_33_2","first-page":"794.","volume":"337","year":"1991","unstructured":"Jacobson, S. K., R. Y. Calne, and T. G. Wreghitt. 1991. Outcome of HIV infection in transplant patient on cyclosporin. Lancet337:794.","journal-title":"Lancet"},{"key":"e_1_3_2_34_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/29.2.464"},{"key":"e_1_3_2_35_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.10.4441"},{"key":"e_1_3_2_36_2","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1097\/00007890-199101000-00038","volume":"51","year":"1991","unstructured":"Kahan, B. D., S. Gibbons, N. Tejpal, S. M. Stepkowski, and T. C. Chou. 1991. Synergistic interactions of cyclosporin and rapamycin to inhibit immune performances of normal human peripheral blood lymphocytes in vitro. Transplantation51:232-239.","journal-title":"Transplantation"},{"key":"e_1_3_2_37_2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0165-2478(89)90129-6","volume":"23","year":"1989","unstructured":"Kay, J. E., and C. R. Benzie. 1989. T lymphocyte activation through the C28 pathway is insensitive to inhibition by the immunosuppressive drug FK-506. Immunol. Lett.23:155-159.","journal-title":"Immunol. Lett."},{"key":"e_1_3_2_38_2","first-page":"544","volume":"72","year":"1991","unstructured":"Kay, J. E., L. Kromwel, S. E. Doe, and M. Denyer. 1991. Inhibition of T and B lymphocyte proliferation by rapamycin. Immunology72:544-549.","journal-title":"Immunology"},{"key":"e_1_3_2_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/3293"},{"key":"e_1_3_2_40_2","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1097\/00007890-199102000-00041","volume":"51","year":"1991","unstructured":"Kimball, P. M., R. H. Kerman, and B. D. Kahan. 1991. Production of synergistic but nonidentical mechanisms of immunosuppression by rapamycin and cyclosporin. Transplantation51:486-490.","journal-title":"Transplantation"},{"key":"e_1_3_2_41_2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00042560-199902010-00001","volume":"20","year":"1999","unstructured":"Kitamura, Y., T. Ishikawa, N. Okui, N. Kobayashi, T. Kanda, T. Shimada, K. Miyake, and K. Yoshiike. 1999. Inhibition of replication of HIV-1 at both early and late stages of the viral life cycle by single-chain antibody against viral integrase. J. Acquired Immune Defic. Syndr. Hum. Retrovirol.20:105-114.","journal-title":"Syndr. Hum. Retrovirol."},{"key":"e_1_3_2_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0021-9673(01)87461-6"},{"key":"e_1_3_2_43_2","doi-asserted-by":"publisher","DOI":"10.1016\/0022-2836(82)90269-8"},{"key":"e_1_3_2_44_2","first-page":"20","volume":"72","year":"2000","unstructured":"Matsushita, S. 2000. Current status and future issues in the treatment of HIV-1 infection. Int. J. Hematol.72:20-27.","journal-title":"Int. J. Hematol."},{"key":"e_1_3_2_45_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.16.6.2857"},{"key":"e_1_3_2_46_2","doi-asserted-by":"publisher","DOI":"10.1038\/10462"},{"key":"e_1_3_2_47_2","first-page":"964","volume":"28","year":"1996","unstructured":"Molnar-Kimber, K. L. 1996. Mechanism of action of rapamycin (Sirolimus, Rapamune). Transplant. Proc.28:964-969.","journal-title":"Transplant. Proc."},{"key":"e_1_3_2_48_2","doi-asserted-by":"crossref","first-page":"3734","DOI":"10.1016\/S0021-9258(18)53755-8","volume":"268","year":"1993","unstructured":"Morice, W. G., G. J. Brunn, G. Wiederrecht, J. J. Siekierka, and R. T. Abraham. 1993. Rapamycin-induced inhibition of p34cdc2 kinase activation is associated with G1\/S-phase growth arrest in T lymphocytes. J. Biol. Chem.268:3734-3738.","journal-title":"J. Biol. Chem."},{"key":"e_1_3_2_49_2","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/377358a0","volume":"377","year":"1995","unstructured":"Nielsen, F. C., L. Ostergaard, J. Nielsen, and J. Christiansen. 1995. Growth-dependent translation of IGF-II mRNA by a rapamycin-sensitive pathway. Nature377:358-362.","journal-title":"Nature"},{"key":"e_1_3_2_50_2","doi-asserted-by":"publisher","DOI":"10.1038\/357692a0"},{"key":"e_1_3_2_51_2","doi-asserted-by":"publisher","DOI":"10.1038\/382833a0"},{"key":"e_1_3_2_52_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.2000.0311"},{"key":"e_1_3_2_53_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.90.18.8392"},{"key":"e_1_3_2_54_2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1310\/B6T0-N98J-1J3M-EQPK","volume":"3","year":"2002","unstructured":"Press, N., G. Kimel, M. Harris, B. Yip, K. J. Craib, and J. S. Montaner. 2002. Case series assessing the safety of mycophenolate as part of multidrug rescue treatment regimens. HIV Clin. Trials3:17-20.","journal-title":"HIV Clin. Trials"},{"key":"e_1_3_2_55_2","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/S0006-2952(98)00339-6","volume":"57","year":"1999","unstructured":"Proudfoot, A. E., T. N. Wells, and P. R. Clapham. 1999. Chemokine receptors\u2014future therapeutic targets for HIV? Biochem. Pharmacol.57:451-463.","journal-title":"Biochem. Pharmacol."},{"key":"e_1_3_2_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/35073673"},{"key":"e_1_3_2_57_2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1172\/JCI0214522","volume":"109","year":"2002","unstructured":"Rizzardi, G. P., A. Harari, B. Capiluppi, G. Tambussi, K. Ellefsen, D. Ciuffreda, P. Champagne, P. A. Bart, J. P. Chave, A. Lazzarin, and G. Pantaleo. 2002. Treatment of primary HIV-1 infection with cyclosporin A coupled with highly active antiretroviral therapy. J. Clin. Investig.109:681-688.","journal-title":"J. Clin. Investig."},{"key":"e_1_3_2_58_2","first-page":"83","volume":"16","year":"2002","unstructured":"Rizzardi, G. P., A. Lazzarin, and G. Pantaleo. 2002. Potential role of immune modulation in the effective long-term control of HIV-1 infection. J. Biol. Regul. Homeost. Agents16:83-90.","journal-title":"J. Biol. Regul. Homeost. Agents"},{"key":"e_1_3_2_59_2","doi-asserted-by":"publisher","DOI":"10.1002\/(SICI)1097-4644(19991201)75:3<357::AID-JCB1>3.0.CO;2-K"},{"key":"e_1_3_2_60_2","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1099\/0022-1317-82-2-435","volume":"82","year":"2001","unstructured":"Rose, N., and A. Lever. 2001. The rapamycin sensitivity of human T-cell leukaemia virus type I-induced T-cell proliferation is mediated independently of the polypyrimidine motifs in the 5\u2032 long terminal repeat. J. Gen. Virol.82:435-439.","journal-title":"J. Gen. Virol."},{"key":"e_1_3_2_61_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1997.8485"},{"key":"e_1_3_2_62_2","doi-asserted-by":"publisher","DOI":"10.1016\/0378-1119(90)90032-M"},{"key":"e_1_3_2_63_2","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/25.4.861"},{"key":"e_1_3_2_64_2","doi-asserted-by":"publisher","DOI":"10.1128\/MCB.15.8.4597"},{"key":"e_1_3_2_65_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.68.5.3071-3079.1994"},{"key":"e_1_3_2_66_2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1006\/viro.1998.9155","volume":"245","year":"1998","unstructured":"Streblow, D. N., M. Kitabwalla, M. Malkovsky, and C. D. Pauza. 1998. Cyclophilin a modulates processing of human immunodeficiency virus type 1 p55Gag: mechanism for antiviral effects of cyclosporin A. Virology245:197-202.","journal-title":"Virology"},{"key":"e_1_3_2_67_2","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/0006-291X(92)90275-P","volume":"189","year":"1992","unstructured":"Suzuki, Y. J., B. B. Aggarwal, and L. Packer. 1992. \u03b1-Lipoic acid is a potent inhibitor of NF-\u03baB activation in human T cells. Biochem. Biophys. Res. Commun.189:1709-1715.","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"e_1_3_2_68_2","doi-asserted-by":"publisher","DOI":"10.1128\/jvi.71.12.9383-9391.1997"},{"key":"e_1_3_2_69_2","doi-asserted-by":"publisher","DOI":"10.1006\/jmbi.2001.4971"},{"key":"e_1_3_2_70_2","doi-asserted-by":"publisher","DOI":"10.1006\/viro.1999.9944"},{"key":"e_1_3_2_71_2","doi-asserted-by":"crossref","first-page":"11477","DOI":"10.1073\/pnas.91.24.11477","volume":"91","year":"1994","unstructured":"Terada, N., H. R. Patel, K. Takase, K. Kohno, A. C. Nairn, and E. W. Gelfand. 1994. Rapamycin selectively inhibits translation of mRNAs encoding elongation factors and ribosomal proteins. Proc. Natl. Acad. Sci. USA91:11477-11481.","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"e_1_3_2_72_2","doi-asserted-by":"publisher","DOI":"10.1038\/372363a0"},{"key":"e_1_3_2_73_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0955-0674(97)80078-6"},{"key":"e_1_3_2_74_2","doi-asserted-by":"publisher","DOI":"10.1177\/095632029800900301"},{"key":"e_1_3_2_75_2","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1136\/bmj.322.7299.1410","volume":"322","year":"2001","unstructured":"Weller, I. V., and I. G. Williams. 2001. ABC of AIDS Antiretroviral drugs. Br. Med. J.322:1410-1412.","journal-title":"Br. Med. J."},{"key":"e_1_3_2_76_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.87.17.6713"},{"key":"e_1_3_2_77_2","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.91.20.9564"},{"key":"e_1_3_2_78_2","doi-asserted-by":"publisher","DOI":"10.1128\/JVI.72.8.6430-6436.1998"},{"key":"e_1_3_2_79_2","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/00007890-199407000-00015","volume":"58","year":"1994","unstructured":"Zheng, X. X., T. B. Strom, and A. W. Steele. 1994. Quantitative comparison of rapamycin and cyclosporin effects on cytokine gene expression studied by reverse transcriptase-competitive polymerase chain reaction. Transplantation58:87-92.","journal-title":"Transplantation"}],"container-title":["Antimicrobial Agents and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.11.3447-3455.2002","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.asm.org\/doi\/pdf\/10.1128\/AAC.46.11.3447-3455.2002","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,24]],"date-time":"2023-04-24T23:13:20Z","timestamp":1682378000000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.asm.org\/doi\/10.1128\/AAC.46.11.3447-3455.2002"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,11]]},"references-count":78,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2002,11]]}},"alternative-id":["10.1128\/AAC.46.11.3447-3455.2002"],"URL":"https:\/\/doi.org\/10.1128\/aac.46.11.3447-3455.2002","relation":{},"ISSN":["0066-4804","1098-6596"],"issn-type":[{"value":"0066-4804","type":"print"},{"value":"1098-6596","type":"electronic"}],"subject":[],"published":{"date-parts":[[2002,11]]},"assertion":[{"value":"2002-01-08","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-08-16","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2002-11-01","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}